Members of ICCR believe that health care is a human right that should be affordable and accessible to all, especially the economically poor and vulnerable. We all must work together to reduce health care costs and further extend coverage. We are convinced the Affordable Care Act (ACA) is a strong foundation on which to build a more humane world.
The ACA is largely responsible for extending health care coverage to over 20 million previously uninsured Americans – by any standard a remarkable accomplishment that should be celebrated. While we know there is still work to be done, particularly in controlling costs, we urge Congress and the incoming administration to work with key stakeholders to improve the law rather than un-do the significant progress that has been made.
In 2010, ICCR members pressed health insurers and large employers to help ensure the passage of ACA and the implementation of robust insurance exchanges.
Featured ICCR Initiatives
1. Investors defend the Affordable Care Act. Amid election promises of an immediate repeal of the Affordable Care Act (ACA), ICCR and a coalition of 119 faith- and values-based investors and public health groups sent a letter to members of Congress and President Trump strongly defended the gains made under the law and urging restraint.
2. Challenging Pharmaceutical Industry Lobbying. Pharmaceutical companies, health insurers, and medical device manufacturers lobby heavily on issues related to health care, donating significant and often undisclosed sums to political candidates, parties and PACs that in turn, promote public policy and legislation that protects their interests. This flood of corporate money is just one of the legacies of the Supreme Court’s 2010 Citizens United decision.
Most pharmaceutical companies are also members of industry groups like the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Industry Organization (“BIO”). PhRMA and its member companies spent $40 million lobbying Congress to prevent the passage of the Affordable Care Act. Many drug companies are also members of the conservative model legislation group the American Legislative Exchange Council (ALEC). ALEC has sought to privatize both Medicare and Medicaid, and repeal important laws that would expand access to health care.
ICCR members have filed resolutions with 6 companies (see sample resolution) calling for greater transparency on their lobbying activities. The companies receiving resolutions are:
- Johnson & Johnson
- Vertex Pharmaceuticals|
- Wallgreens Boots Alliance